AD2-22841-06877
1 vaccination
4 coded responses
5 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 673 / KS
- Registered
- 2021-08-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-01
Dose 1 — Pfizer-BioNTech
-
2021-08-02
Registered in v-safe
-
2021-08-02
Survey response — days 1–6 daily, dose 1MedDRA: Injection site urticaria, Pain in extremity, Self-medication — Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaFree text: Pain in other arm in the same place as injection spot. Slight hives around injection sight and on other arm ( not severe case, treating with allergy meds)MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-05
Survey response — days 1–6 daily, dose 1MedDRA: Injection site urticaria — Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tiredness, NauseaFree text: Hives around injection site since injection (not as bad as the first injection)MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-08
Survey response — day 7, dose 1MedDRA: Dysgeusia, Fatigue, Hypoaesthesia, Paraesthesia, Swelling face — Feeling: Fair · Site: Swelling, Itching · Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Have metallic taste in mouth, face is swollen with numb tingling feeling in face. Completely exhausted.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-15
Survey response — day 14, dose 1MedDRA: Fatigue, Headache, Hypoaesthesia oral, Paraesthesia, Swelling face — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Severe headache. Numbness in tongue. Extreme exhaustion. Continued tingling and swelling in faceMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-01 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Pain in other arm in the same place as injection spot. Slight hives around injection sight and on other arm ( not severe case, treating with allergy meds)
Systemic reaction (other): Hives around injection site since injection (not as bad as the first injection)
Release 9 — day 7, dose 1
Systemic reaction (other): Have metallic taste in mouth, face is swollen with numb tingling feeling in face. Completely exhausted.
Release 9 — day 14, dose 1
Symptoms: Severe headache. Numbness in tongue. Extreme exhaustion. Continued tingling and swelling in face
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | ✓ | · | ✓ |
| SD | Headache | ✓ | · | ✓ |
| SD | Hypoaesthesia oral | ✓ | · | ✓ |
| SD | Paraesthesia | ✓ | · | ✓ |
| SD | Swelling face | ✓ | · | ✓ |
| SRO | Dysgeusia | ✓ | · | ✓ |
| SRO | Fatigue | ✓ | · | ✓ |
| SRO | Hypoaesthesia | ✓ | · | ✓ |
| SRO | Injection site urticaria | ✓ | · | ✓ |
| SRO | Pain in extremity | ✓ | · | ✓ |
| SRO | Paraesthesia | ✓ | · | ✓ |
| SRO | Self-medication | ✓ | · | ✓ |
| SRO | Swelling face | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release